Use of Valproic Acid in Complex Therapy of Post-Covid Mental Disorders (Clinical Case)
Raspopova N.I.
30 June 2024IP Kostyukova Elena Grigorievna
Sovremennaa Terapia Psihiceskih Rasstrojstv
2024#2024Issue 256 - 67 pp.
The results of recent international studies indicate that individuals who have had COVID-19, in the clinic of post-covid syndrome, often experience mental disorders in the form of increased irritability, depressed mood, anxiety, memory impairment and reduced intellectual productivity. The researchers pay particular attention to the most common anxiety-depressive disorders, which significantly reduce the quality of life and in some cases can increase the risk of suicide, which determines the relevance and social importance of developing measures to improve the quality of psychiatric care for these individuals. This paper presents a clinical case demon-strating the clinic and dynamics of the development of a protracted course of post-covid anxiety-depressive disorder and the selection of effective complex psycho-pharmacotherapy using the valproic acid. The advisability of including drugs from the group of mood stabilizers in the complex psychopharmacotherapy of protracted forms of post-covid mental disorders is discussed.
anxiety , depression , post-covid mental disorders , valproic acid
Text of the article Перейти на текст статьи
Kazakh-Russian Medical University, Almaty, Kazakhstan
Kazakh-Russian Medical University
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026